Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...

According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India.

Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check ...

The Ahmedabad-based pharmaceutical firm's shares listed at Rs 600 on the National Stock Exchange, a premium of 53.45%.

Senores Pharmaceuticals IPO sees robust demand, with potential listing gain of 59%, scheduled to list on BSE and NSE.

The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the ...

At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) The ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

The grey market premium of Senores Pharmaceuticals IPO was Rs 240 as of 05:04 a.m. on Dec. 26, indicating a strong gain of 61 ...